By Fineline Cube 
Peijia Medical Technology (Suzhou) Co., Ltd. today held a strategic innovation cooperation signing ceremony and press conference to announce the research and development achievements of polymer heart valves using ultra-high molecular weight polyethylene (UHMWPE) and thermoplastic polyurethane (TPU) from the Biomedical business of DSM-Firmenich. This collaboration marks a significant advancement in the innovation of polymer heart valve materials.
Partnership Details
Peijia Medical, a leading enterprise in high-end medical devices for structural heart disease and cerebrovascular intervention in China, has partnered with DSM-Firmenich’s Biomedical business to further develop innovative polymer heart valve materials. The collaboration focuses on leveraging UHMWPE and TPU to enhance the performance and longevity of heart valve replacements.
Polymer Valve Innovation
Peijia Medical’s independently developed polymer valve utilizes a five-layer bionic polymer fiber fabric as the valve material, mimicking the functions of the human body’s natural valve leaflets. This innovative design aims to provide a longer lifespan than current biological source valve materials, offering significant advantages in durability and functionality.
Collaborative Research and Development
Through this strategic partnership, Peijia Medical and DSM-Firmenich will establish a long-term, stable, and mutually beneficial relationship. Joint R&D efforts will focus on the design and development of new high-end medical device products, optimization of key raw material properties, and the development of advanced manufacturing processes and technologies based on UHMWPE materials.-Fineline Info & Tech